Literature DB >> 30988931

Epidemiology of Hepatitis C.

Syed-Mohammed Jafri1, Stuart C Gordon1.   

Abstract

Year:  2018        PMID： 30988931      PMCID： PMC6385933          DOI： 10.1002/cld.783

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  8 in total

1.  Emissions of dioxins and dioxin-like compounds and incidence of hepatocellular carcinoma in the United States.

Authors:  Trang VoPham; Kimberly A Bertrand; Jared A Fisher; Mary H Ward; Francine Laden; Rena R Jones
Journal:  Environ Res       Date:  2021-11-17       Impact factor: 6.498

2.  Revolution in the diagnosis and management of hepatitis C virus infection in current era.

Authors:  Farina M Hanif; Zain Majid; Nasir Hassan Luck; Abbas Ali Tasneem; Syed Muddasir Laeeq; Muhammed Mubarak
Journal:  World J Hepatol       Date:  2022-04-27

3.  Population Pharmacokinetic Analysis of Yimitasvir in Chinese Healthy Volunteers and Patients With Chronic Hepatitis C Virus Infection.

Authors:  Xiao-Duo Guan; Xian-Ge Tang; Ying-Jun Zhang; Hong-Ming Xie; Lin Luo; Dan Wu; Rui Chen; Pei Hu
Journal:  Front Pharmacol       Date:  2021-01-28       Impact factor: 5.810

4.  [Seroprevalence of hepatitis C virus (HCV) antibodies and associated factors based on voluntary screening data collection in the general population in Benin in 2016].

Authors:  Aboudou Raïmi Kpossou; Benoît Kouwakanou; Comlan N Déhougbèa Martin Sokpon; Khadidjatou Saké Alassane; Marc Moboladji Bankolé; Carin Ahouada; Rodolph Koffi Vignon; Vincent Zoundjiekpon; Fadel Sourokou; Jean Séhonou; Nicolas Kodjoh
Journal:  Pan Afr Med J       Date:  2021-09-10

Review 5.  Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses.

Authors:  Yannick Tréguier; Anne Bull-Maurer; Philippe Roingeard
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

6.  Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID.

Authors:  Kyung-Ah Kim; Gwang Hyun Choi; Eun Sun Jang; Young Seok Kim; Youn Jae Lee; In Hee Kim; Sung Bum Cho; Moran Ki; Hwa Young Choi; Dahye Paik; Sook-Hyang Jeong
Journal:  Epidemiol Health       Date:  2021-10-06

7.  PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV.

Authors:  Kristi C Hill; Sarah M Kattakuzhy; Rachel Silk; Rahwa Eyasu; Onyinyechi Ogbumbadiugha; Emade Ebah; Amelia A Cover; Ashley Davis; Britt Gayle; David Sternberg; Phyllis Bijole; Junfeng Sun; Henry Masur; Shyam Kottilil; Daniel Solomon; Elana S Rosenthal
Journal:  Open Forum Infect Dis       Date:  2022-09-14       Impact factor: 4.423

8.  Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil.

Authors:  Rodrigo Gardona; Flavia Appel; Samara Ercolin; Roberto J Carvalho-Filho; Dulce A Barbosa; Maria Lucia Ferraz
Journal:  Braz J Infect Dis       Date:  2021-02-23       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.